145 related articles for article (PubMed ID: 32021575)
1. Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study.
Ghasemi-Jangjoo A; Ghiasi H
Rep Pract Oncol Radiother; 2020; 25(2):187-192. PubMed ID: 32021575
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of 18-MV grid therapy from radiation protection aspects: unwanted dose and fatal cancer risk caused by photoneutrons and scattered photons.
Karimi AH; Mirian SF; Mahmoudi F; Geraily G; Vega-Carrillo HR; Mohiuddin M
Comput Methods Programs Biomed; 2022 Jan; 213():106524. PubMed ID: 34818621
[TBL] [Abstract][Full Text] [Related]
4. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
Front Oncol; 2022; 12():882489. PubMed ID: 35756661
[TBL] [Abstract][Full Text] [Related]
5. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
6. Photoneutron Dose Estimation in GRID Therapy Using an Anthropomorphic Phantom: A Monte Carlo Study.
Chegeni N; Karimi AH; Jabbari I; Arvandi S
J Med Signals Sens; 2018; 8(3):175-183. PubMed ID: 30181966
[TBL] [Abstract][Full Text] [Related]
7. Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.
Elmtalab S; Abedi I; Alirezaei Z; Choopan Dastjerdi MH; Geraily G; Karimi AH
PLoS One; 2022; 17(7):e0271028. PubMed ID: 35905102
[TBL] [Abstract][Full Text] [Related]
8. Shielding implications for secondary neutrons and photons produced within the patient during IMPT.
DeMarco J; Kupelian P; Santhanam A; Low D
Med Phys; 2013 Jul; 40(7):071701. PubMed ID: 23822405
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo calculation of photo-neutron dose produced by circular cones at 18 MV photon beams.
Hosseinzadeh E; Banaee N; Nedaie HA
Rep Pract Oncol Radiother; 2018; 23(1):39-46. PubMed ID: 29348733
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo simulation estimates of neutron doses to critical organs of a patient undergoing 18 MV x-ray LINAC-based radiotherapy.
Barquero R; Edwards TM; Iñiguez MP; Vega-Carrillo HR
Med Phys; 2005 Dec; 32(12):3579-88. PubMed ID: 16475756
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo evaluation of out-of-field dose in 18 MV pelvic radiotherapy using a simplified female MIRD phantom.
Geraily G; Elmtalab S; Mohammadi N; Alirezaei Z; Martinez-Ovalle SA; Jabbari I; Vega-Carrillo HR; Karimi AH
Biomed Phys Eng Express; 2021 Nov; 8(1):. PubMed ID: 34727526
[TBL] [Abstract][Full Text] [Related]
12. Estimation of organs doses and radiation-induced secondary cancer risk from scattered photons for conventional radiation therapy of nasopharynx: a Monte Carlo study.
Mesbahi A; Seyednejad F; Gasemi-Jangjoo A
Jpn J Radiol; 2010 Jun; 28(5):398-403. PubMed ID: 20585932
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the linac neutron dose profile for various depths and field sizes: a Monte Carlo study.
Prasada DNY; Ciamaudi N; Fadli M; Tursinah R; Pawiro SA
Biomed Phys Eng Express; 2021 Oct; 7(6):. PubMed ID: 34619664
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo estimation of photoneutrons contamination from high-energy X-ray medical accelerators in treatment room and maze: a simplified model.
Zabihzadeh M; Ay MR; Allahverdi M; Mesbahi A; Mahdavi SR; Shahriari M
Radiat Prot Dosimetry; 2009 Jul; 135(1):21-32. PubMed ID: 19483207
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
16. Doses to patients from photoneutrons emitted in a medical linear accelerator.
Saeed MK; Moustafa O; Yasin OA; Tuniz C; Habbani FI
Radiat Prot Dosimetry; 2009 Feb; 133(3):130-5. PubMed ID: 19287045
[TBL] [Abstract][Full Text] [Related]
17. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
Chibani O; Ma CM
Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Photoneutron Dose Measured by Bubble Detectors in Conventional Linacs and Cyberknife Unit: Effective Dose and Secondary Malignancy Risk Estimation.
Biltekin F; Yeginer M; Ozyigit G
Technol Cancer Res Treat; 2016 Aug; 15(4):560-5. PubMed ID: 26152750
[TBL] [Abstract][Full Text] [Related]
19. Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer.
Fontenot J; Taddei P; Zheng Y; Mirkovic D; Jordan T; Newhauser W
Phys Med Biol; 2008 Mar; 53(6):1677-88. PubMed ID: 18367796
[TBL] [Abstract][Full Text] [Related]
20. PHITS simulations of absorbed dose out-of-field and neutron energy spectra for ELEKTA SL25 medical linear accelerator.
Puchalska M; Sihver L
Phys Med Biol; 2015 Jun; 60(12):N261-70. PubMed ID: 26057186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
